Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Vaccine

• Publication date

  2007-09-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.VACCINE.2007.06.062PMID 17675182
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Novel Functional CTL Avidity/Activity Compartmentalization to the Site of Mucosal Immunization Contributes to Protection of Macaques against Simian/Human Immunodeficiency Viral Depletion of Mucosal CD4+ T Cells

  2007cited by this paper
• Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria.

  2007cited by this paper
• Intranasal Coadministration of Live Lactococci Producing Interleukin-12 and a Major Cow's Milk Allergen Inhibits Allergic Reaction in Mice

  2007cited by this paper
• Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1

  2006cited by this paper
• Recombinant Salmonella vaccines for biodefence.

  2006cited by this paper
• Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral

  2006cited by this paper
• Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations

  2006cited by this paper
• Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A

  2006cited by this paper
• Cell-surface display of E7 antigen from human papillomavirus type-16 in Lactococcus lactis and in Lactobacillus plantarum using a new cell-wall anchor from lactobacilli

  2005cited by this paper
• Commensal gut bacteria: mechanisms of immune modulation.

  2005cited by this paper
• Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids.

  2005cited by this paper
• A Novel Mucosal Vaccine Based on Live Lactococci Expressing E7 Antigen and IL-12 Induces Systemic and Mucosal Immune Responses and Protects Mice against Human Papillomavirus Type 16-Induced Tumors

  2005influential reference
• Induction of Mucosal B-Cell Memory by Intranasal Immunization of Mice with Respiratory Syncytial Virus

  2005cited by this paper
• Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii

  2005cited by this paper
• Factors influencing the immune response to foreign antigen expressed in recombinant BCG vaccines.

  2005cited by this paper
• Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis.

  2005cited by this paper
• Potential and opportunities for use of recombinant lactic acid bacteria in human health.

  2004cited by this paper
• An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococci.

  2004influential reference
• Mucosal and Cellular Immune Responses Elicited by Recombinant Lactococcus lactis Strains Expressing Tetanus Toxin Fragment C

  2004cited by this paper
• Protective immunity of SpaA‐antigen producing Lactococcus lactis against Erysipelothrix rhusiopathiae infection

  2004cited by this paper
• Recent advances in the use of Lactococcus lactis as live recombinant vector for the development of new safe mucosal vaccines

  2004cited by this paper
• Intranasal Immunization with Recombinant Lactococcus lactis Secreting Murine Interleukin-12 Enhances Antigen-Specific Th1 Cytokine Production

  2003cited by this paper
• Use of Mouse Models To Evaluate the Persistence, Safety, and Immune Modulation Capacities of Lactic Acid Bacteria

  2003cited by this paper
• Mice immunization with live lactococci displaying a surface anchored HPV-16 E7 oncoprotein.

  2003cited by this paper
• Elicitation of the allergic reaction in β‐lactoglobulin‐sensitized Balb/c mice: biochemical and clinical manifestations differ according to the structure of the allergen used for challenge

  2003cited by this paper
• Production of Human Papillomavirus Type 16 E7 Protein in Lactococcus lactis

  2002cited by this paper
• IL-12 Inhibition of Endothelial Cell Functions and Angiogenesis Depends on Lymphocyte-Endothelial Cell Cross-Talk1

  2001cited by this paper
• Mucosal Immune Responses and Protection against Tetanus Toxin after Intranasal Immunization with RecombinantLactobacillus plantarum

  2001cited by this paper
• Pharmacokinetics of Lactobacillus plantarum NCIMB 8826, Lactobacillus fermentum KLD, and Lactococcus lactis MG 1363 in the human gastrointestinal tract

  2000cited by this paper
• Intranasal Immunization with Heat-InactivatedStreptococcus pneumoniae Protects Mice against Systemic Pneumococcal Infection

  1999cited by this paper
• Survival, Physiology, and Lysis ofLactococcus lactis in the Digestive Tract

  1999cited by this paper
• Oral vaccination of mice against tetanus with recombinant Lactococcus lactis

  1997cited by this paper
• Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen.

  1996cited by this paper
• Humoral and cellular immune responses in the murine respiratory tract following oral immunization with cholera toxin or Escherichia coli heat-labile enterotoxin.

  1996cited by this paper
• Lactic acid bacteria as vaccine delivery vehicles

  1996cited by this paper
• On the safety of lactic acid bacteria from food.

  1995cited by this paper
• Genetic marking of Lactococcus lactis shows its survival in the human gastrointestinal tract

  1995cited by this paper
• Live attenuated Shigella flexneri mutants as vaccine candidates against shigellosis and vectors for antigen delivery.

  1995cited by this paper
• Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo

  1995cited by this paper
• Role of interferon-gamma in mediating the antitumor efficacy of interleukin-12.

  1995cited by this paper
• Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells

  1993cited by this paper
• A "public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes.

  1991cited by this paper
• Synthetic peptides derived from E7 region of human papillomavirus type 16 used as antigens in ELISA.

  1990cited by this paper

• Immunogenic Responses Elicited by a Pool of Recombinant Lactiplantibacillus plantarum NC8 Strains Surface-Displaying Diverse African Swine Fever Antigens Administered via Different Immunization Routes in a Mouse Model

  2025cites this paper
• The Immunomodulatory Effects and Applications of Probiotic Lactiplantibacillus plantarum in Vaccine Development

  2024cites this paper
• Necrotic enteritis in chickens: a comprehensive review of vaccine advancements over the last two decades

  2024cites this paper
• Bacterial derivatives mediated drug delivery in cancer therapy: a new generation strategy

  2024cites this paper
• Enhancement of live vaccines by co-delivery of immune modulating proteins.

  2022cites this paper
• Use of genetically modified lactic acid bacteria and bifidobacteria as live delivery vectors for human and animal health

  2022cites this paper
• Oral or intranasal immunization with recombinant Lactobacillus plantarum displaying head domain of Swine Influenza A virus hemagglutinin protects mice from H1N1 virus

  2022cites this paper
• Probiotics as Edible Vaccines

  2021cites this paper
• Lactiplantibacillus plantarum as a Potential Adjuvant and Delivery System for the Development of SARS-CoV-2 Oral Vaccines

  2021cites this paper
• Bacteria and bacterial derivatives as delivery carriers for immunotherapy.

  2021cites this paper
• Recombinant lactic acid bacteria as promising vectors for mucosal vaccination

  2021cites this paper
• Both‐In‐One Hybrid Bacteria Suppress the Tumor Metastasis and Relapse via Tandem‐Amplifying Reactive Oxygen Species‐Immunity Responses

  2021cites this paper
• Inhibition of acetic acid-induced colitis in rats by new Pediococcus acidilactici strains, vitamin producers recovered from human gut microbiota

  2021cites this paper
• Evaluation of a subunit vaccine candidate (Biotech Vac Cox) against Eimeria spp. in broiler chickens

  2021cites this paper
• Novel Strategies for Efficient Production and Delivery of Live Biotherapeutics and Biotechnological Uses of Lactococcus lactis: The Lactic Acid Bacterium Model

  2020cites this paper
• Adjuvant effects of killed Lactobacillus casei DK128 on enhancing T helper type 1 immune responses and the efficacy of influenza vaccination in normal and CD4-deficient mice.

  2020cites this paper
• Adjuvant Strategies for Lactic Acid Bacterial Mucosal Vaccines

  2019cites this paper
• Genetic Operation System of Lactic Acid Bacteria and Its Applications

  2019cites this paper
• Expression of a leptospiral leucine-rich repeat protein using a food-grade vector in Lactobacillus plantarum, as a strategy for vaccine delivery

  2019cites this paper
• Elucidating the Immune-Related Mechanisms by Which Probiotic Strain Lactobacillus casei BL23 Displays Anti-tumoral Properties

  2019cites this paper
• Expression of the alpha toxin of Clostridium perfringens in Lactobacillus casei genome and evaluation of its immune effects in mice.

  2018cites this paper
• Lactobacillus Mucosal Vaccine Vectors: Immune Responses against Bacterial and Viral Antigens

  2018cites this paper
• The Use of Probiotics as Vaccine Vectors to Prevent Viral Infections

  2017cites this paper
• Cloning and Expression of Listeriolysin O in Lactobacillus plantarum

  2017cites this paper
• Therapeutic DNA Vaccines: The Final Step for Success

  2017cites this paper
• Recombinant Lactococcus lactis Expressing Haemagglutinin from a Polish Avian H5N1 Isolate and Its Immunological Effect in Preliminary Animal Trials

  2017cites this paper
• Lactococcus lactis : A New Strategy for Vaccination

  2017cites this paper
• Immunization with r‐Lactococcus lactis expressing outer membrane protein A of Shigella dysenteriae type‐1: evaluation of oral and intranasal route of administration

  2017influential citation
• HIV prophylaxis : an essential role for T cells and adjuvants in recombinant mucosal Lactobacillus acidophilus vaccines

  2017cites this paper
• Bioengineered and biohybrid bacteria-based systems for drug delivery.

  2016cites this paper
• Biosystems Engineering of Prokaryotes with Tumor-Killing Capacities.

  2016cites this paper
• Expression of fibronectin binding protein A (FnBPA) from Staphylococcus aureus at the cell surface of Lactococcus lactis improves its immunomodulatory properties when used as protein delivery vector.

  2016cites this paper
• A new lactobacilli in vivo expression system for the production and delivery of heterologous proteins at mucosal surfaces.

  2016cites this paper
• Lactococcus lactis as a live delivery vector

  2016cites this paper
• CXCR4(+)-targeted protein nanoparticles produced in the food-grade bacterium Lactococcus lactis.

  2016cites this paper
• Live bacterial vaccine vectors: An overview

  2015influential citation
• Recombinant Lactobacillus plantarum induces immune responses to cancer testis antigen NY-ESO-1 and maturation of dendritic cells

  2015cites this paper
• Human Papillomavirus Vaccine: State of the Art and Future Perspectives.

  2015cites this paper
• Surface display of an anti-DEC-205 single chain Fv fragment in Lactobacillus plantarum increases internalization and plasmid transfer to dendritic cells in vitro and in vivo

  2015cites this paper
• Lactic acid bacteria—20 years exploring their potential as live vectors for mucosal vaccination

  2015cites this paper
• Erratum to: Lactic acid bacteria—20 years exploring their potential as live vectors for mucosal vaccination

  2015cites this paper
• Bakterie kwasu mlekowego (LAB) jako wektory do konstrukcji szczepionek

  2015cites this paper
• Antigen Delivery System II

  2015cites this paper
• Future Clinical Applications of the Potential use of Lactic Acid Bacteria as Vehicles to Deliver DNA Vaccines

  2015cites this paper
• Comparative mucosal immunogenicity of HIV gp41 membrane-proximal external region (MPER) containing single and multiple repeats of ELDKWA sequence with defensin peptides.

  2014cites this paper
• Oral vaccination against HPV E7 for treatment of cervical intraepithelial neoplasia grade 3 (CIN3) elicits E7-specific mucosal immunity in the cervix of CIN3 patients.

  2014cites this paper
• Lactobacillus mediated targeting of gastrointestinal pathogens

  2014cites this paper
• Nasal delivery of PLG microparticle encapsulated defensin peptides adjuvanted gp41 antigen confers strong and long-lasting immunoprotective response against HIV-1

  2014cites this paper
• Passive protection of mice pups through oral or intranasal immunization of dams with recombinant Lactobacillus casei vaccine against ETEC F41.

  2014cites this paper
• Modulation of peanut-induced allergic immune responses by oral lactic acid bacteria-based vaccines in mice

  2014cites this paper
• Immune Response Elicited by DNA Vaccination Using Lactococcus lactis Is Modified by the Production of Surface Exposed Pathogenic Protein

  2014cites this paper
• Pushing the Bacterial Envelope

  2014cites this paper
• Intranasal immunization with recombinant Lactococci carrying human papillomavirus E7 protein and mouse interleukin-12 DNA induces E7-specific antitumor effects in C57BL/6 mice

  2013cites this paper
• Induction of specific immune responses in piglets by intramuscular immunization with fimbrial adhesin FaeG expressed in Lactococcus lactis.

  2013cites this paper
• Development of a Stress-Inducible Controlled Expression (SICE) system in Lactococcus lactis for the production and delivery of therapeutic molecules at mucosal surfaces.

  2013cites this paper
• Nasal delivery of PLG microparticle encapsulated defensin peptides adjuvanted gp41 antigen confers strong and long-lasting immunoprotective response against HIV-1

  2013cites this paper
• Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease

  2013cites this paper
• Modulation of Mucosal Antiviral Immune Response at the Female Genital Tract by Immunobiotic Lactic Acid Bacteria

  2013cites this paper
• Avian reovirus sigma C enhances the mucosal and systemic immune responses elicited by antigen-conjugated lactic acid bacteria

  2012cites this paper
• Caracterisation fonctionnelle des sortases de lactococcus lactis : de l’ancrage de protéines à la biogénèse de pili

  2012cites this paper
• Therapeutic Human Papillomavirus (HPV) Vaccines: A Novel Approach

  2012cites this paper
• Immunization with recombinant Lactobacillus casei strains producing K99, K88 fimbrial protein protects mice against enterotoxigenic Escherichia coli.

  2012cites this paper
• vian reovirus sigma C enhances the mucosal and systemic immune responses licited by antigen-conjugated lactic acid bacteria uan

  2012cites this paper
• Lactococcus lactis as a live vector: heterologous protein production and DNA delivery systems.

  2011cites this paper
• Organ system Target Male Female Hypothalamic – pituitary axis Gonadotrophs Gonadotrophs Gonads Germ cell Ovarian follicle Sertoli cell Oocyte Leydig cell Granulosa cell

  2011cites this paper
• Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines

  2011cites this paper
• Intranasal Vaccination with the Recombinant Listeria monocytogenes ΔactA prfA* Mutant Elicits Robust Systemic and Pulmonary Cellular Responses and Secretory Mucosal IgA

  2011cites this paper
• Genetic Engineering of Probiotic Microorganisms

  2011cites this paper
• Mucosal co-immunization of mice with recombinant lactococci secreting VapA antigen and leptin elicits a protective immune response against Rhodococcus equi infection.

  2011cites this paper
• Is there a role for immunocontraception?

  2011cites this paper
• Recombinant lactic acid bacteria as mucosal biotherapeutic agents.

  2011cites this paper
• Immunotherapy for Cervical Cancer

  2010cites this paper
• Oral immunization with a Lactobacillus casei vaccine expressing human papillomavirus (HPV) type 16 E7 is an effective strategy to induce mucosal cytotoxic lymphocytes against HPV16 E7.

  2010cites this paper
• Immune responses elicited in mice with recombinant Lactococcus lactis expressing F4 fimbrial adhesin FaeG by oral immunization

  2010cites this paper
• Cell Wall Anchoring of the 37-Kilodalton Oncofetal Antigen by Lactobacillus plantarum for Mucosal Cancer Vaccine Delivery

  2010cites this paper
• Probiotics and health claims: challenges for tailoring their efficacy.

  2010cites this paper
• Analyse des effets de souches probiotiques anti-inflammatoires

  2010cites this paper
• Secretion of Heterologous Proteins, Gram-Positive Bacteria, Lactococcus lactis

  2010cites this paper
• Variations of N-acetylation level of peptidoglycan do not influence persistence of Lactococcus lactis in the gastrointestinal tract.

  2010cites this paper
• Rotavirus-Like Particles: A Novel Nanocarrier for the Gut

  2010cites this paper
• Development of Mucosal Vaccines Based on Lactic Acid Bacteria

  2009influential citation
• Comparison of the local immune response against Giardia lamblia cyst wall protein 2 induced by recombinant Lactococcus lactis and Streptococcus gordonii.

  2009cites this paper
• Allergy Therapy by Intranasal Administration with Recombinant Lactococcus lactis Producing Bovine β-Lactoglobulin

  2009cites this paper
• Utilisation des bactéries lactiques comme vecteurs vaccinaux

  2009cites this paper
• Human papillomavirus vaccines: current issues & future.

  2009cites this paper
• Influence of the route of administration on immunomodulatory properties of bovine beta-lactoglobulin-producing Lactobacillus casei.

  2009cites this paper
• Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV.

  2009cites this paper
• Induction of Immune Responses in Mice after Oral Immunization with Recombinant Lactobacillus casei Strains Expressing Enterotoxigenic Escherichia coli F41 Fimbrial Protein

  2009cites this paper
• Use of lactobacilli and their pheromone-based regulatory mechanism in gene expression and drug delivery.

  2009cites this paper
• Immunomodulatory properties of Lactobacillus plantarum and its use as a recombinant vaccine against mite allergy

  2009cites this paper
• Induction of neutralizing antibodies against dengue virus type 2 upon mucosal administration of a recombinant Lactococcus lactis strain expressing envelope domain III antigen.

  2008cites this paper
• Production of biologically active CXC chemokines by Lactococcus lactis: evaluation of its potential as a novel mucosal vaccine adjuvant.

  2008cites this paper
• Nasal immunization of mice with Lactobacillus casei expressing the Pneumococcal Surface Protein A: induction of antibodies, complement deposition and partial protection against Streptococcus pneumoniae challenge.

  2008cites this paper
• Oral Immunization with Recombinant Lactobacillus plantarum Induces a Protective Immune Response in Mice with Lyme Disease

  2008cites this paper